<i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
Theresa M. Dulski, Megan DeLong, Kelley Garner, Naveen Patil, Maaike Cima, Laura Rothfeldt, Trent Gulley, Austin Porter, Keyur S. Vyas, Hazel Liverett, Mitsuru Toda, Jeremy A.W. Gold, Atul Kothari
Abstract
During September 17-24, 2021, three clinicians independently notified the Arkansas Department of Health (ADH) of multiple patients with mucormycosis after a recent diagnosis of COVID-19. To provide data to guide clinical and public health practice, ADH coordinated a statewide call on October 11, 2021 to infection preventionists for COVID-19-associated mucormycosis cases.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Mucormycosis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPathologyOutbreakDiseaseInfectious disease (medical specialty)Antifungal resistance and susceptibilityMedical and Biological Ozone ResearchFungal Infections and Studies